We are live on ! Find out more
NMTR

9 Meters Biopharma
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

45 hedge funds and large institutions have $20.1M invested in 9 Meters Biopharma in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 3

183% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 6

101% more call options, than puts

Call options by funds: $859K | Put options by funds: $427K

25% more funds holding

Funds holding: 36 → 45 (+9)

57% less capital invested

Capital invested by funds: $46.7M → $20.1M (-$26.7M)

Holders
45
Holders Change
+9
Holders Change %
+25%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
17
Reduced
6
Closed
3
Calls
$859K
Puts
$427K
Net Calls
+$432K
Net Calls Change
-$1.08M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.59M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.21M
3
Northern Trust
Northern Trust
Illinois
+$1.58M
4
State Street
State Street
Massachusetts
+$993K
5
JG
Jefferies Group
New York
+$848K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$7.84M
2
Bank of America
Bank of America
North Carolina
-$504K
3
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$340K
4
TCIM
TIAA CREF Investment Management
New York
-$210K
5
UBS Group
UBS Group
Switzerland
-$56.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$8.08M +$2.59M +15,057 +34%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.21M +$2.21M +12,887 +387%
State Street
3
State Street
Massachusetts
$1.8M +$993K +5,779 +78%
Northern Trust
4
Northern Trust
Illinois
$1.41M +$1.58M +9,224 +820%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$920K +$748K +4,353 +182%
JG
6
Jefferies Group
New York
$674K +$848K +4,935 New
Morgan Stanley
7
Morgan Stanley
New York
$604K +$297K +1,731 +64%
Millennium Management
8
Millennium Management
New York
$475K +$439K +2,553 +277%
ARTA
9
A.R.T. Advisors
New York
$365K +$459K +2,674 New
Deutsche Bank
10
Deutsche Bank
Germany
$287K +$47.9K +279 +15%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$274K +$9.45K +55 +3%
DWM
12
Dynasty Wealth Management
Florida
$243K +$161K +935 +111%
Charles Schwab
13
Charles Schwab
California
$236K – – –
Wells Fargo
14
Wells Fargo
California
$210K +$64.4K +375 +32%
RJA
15
Raymond James & Associates
Florida
$195K +$245K +1,426 New
California State Teachers Retirement System (CalSTRS)
16
California State Teachers Retirement System (CalSTRS)
California
$193K – – –
TCIM
17
TIAA CREF Investment Management
New York
$177K -$210K -1,223 -49%
FQ
18
First Quadrant
California
$162K +$204K +1,185 New
TA
19
Teachers Advisors
New York
$159K – – –
Russell Investments Group
20
Russell Investments Group
United Kingdom
$150K +$189K +1,099 New
New York State Common Retirement Fund
21
New York State Common Retirement Fund
New York
$141K – – –
Bank of Montreal
22
Bank of Montreal
Ontario, Canada
$138K +$172K +999 +14,271%
HCA
23
Hillview Capital Advisors
Pennsylvania
$134K +$169K +981 New
RhumbLine Advisers
24
RhumbLine Advisers
Massachusetts
$108K -$8.42K -49 -6%
PPA
25
Parametric Portfolio Associates
Washington
$103K +$129K +752 New
1
2

NMTR Hedge Fund Activity: Q3 2018 in Review

45 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q3 2018, worth a combined $20.1M — down 57% from $46.7M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NMTR positions and 3 closed out — a net gain of 9 holders — while 17 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $2.59M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $7.84M sold.

  • 45 institutional investors held 9 Meters Biopharma (NMTR) as of Q3 2018, up from 36 in Q2 2018.
  • Funds reported $20.1M of 9 Meters Biopharma stock for Q3 2018, down 57% quarter-over-quarter.
  • 12 funds opened new 9 Meters Biopharma positions in Q3 2018 and 3 closed out, a net change of +9 holders.
  • The largest 9 Meters Biopharma buyer in Q3 2018 was BlackRock, an estimated $2.59M added.
  • The largest 9 Meters Biopharma seller in Q3 2018 was Sphera Funds Management, an estimated $7.84M sold.

Based on aggregated 13F filings for Q3 2018.